Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Medgenics Inc (NYSE MKT LLC:MDGN)

7.86
Delayed Data
As of Aug 04
 +0.09 / +1.16%
Today’s Change
3.68
Today|||52-Week Range
9.63
+55.34%
Year-to-Date
No recent news for Medgenics Inc.

Today’s Trading

Previous close7.77
Today’s open7.65
Day’s range7.65 - 7.92
Volume72,168
Average volume (3 months)200,728
Market cap$193.5M
Dividend yield--
Data as of 4:01pm ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)+5.66%
Earnings growth (this year)-32.50%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.50

Competitors

 Today’s
change
Today’s
% change
AGRXAgile Therapeutics I...+0.35+4.04%
CYNACynapsus Therapeutic...-0.04-0.25%
NEOTNeothetics Inc+0.20+1.40%
STMLStemline Therapeutic...-0.03-0.29%
Data as of 3:59pm ET, 08/04/2015

Financials

Next reporting dateAugust 17, 2015
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$0.00
Annual profit (last year)-$18.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael F. Cola
Chief Financial Officer
John Harold Leaman
Corporate headquarters
Wayne, Pennsylvania

Forecasts